Cite
HARVARD Citation
Norrenberg, S. et al. (2018). Retrospective study of rapamycin or rapalog 0·1% cream for facial angiofibromas in tuberous sclerosis complex: evaluation of treatment effectiveness and cost. British journal of dermatology. pp. 208-209. [Online].